Projects

International

• Development of Lipopolysaccharide-Biopolymer Complex and Conjugates Against the Q Fever Disease For Application Purpose of Vaccine Prototype and Diagnostic Kit
  Program: Inter-academic agreement
  Duration: 1. 12. 2013 – 30. 6. 2017

• Structural characterisation and anotation of gene cluster of C. burnetii lippoplysaccharide
  Program: Bilateral - other
  Duration: 1. 9. 2015 – 31. 12. 2016

National

• Non-antibiotic approach for the treatment of tick-borne infections
  Program: SRDA
  Duration: 1. 7. 2024 – 30. 6. 2028

• Molecular fundamentals driving tick competence in pathogen transmission
  Program: SRDA
  Duration: 1. 9. 2024 – 30. 6. 2028

• Lipidomic study of the cell membrane of Rickettsia spp.
  Program: VEGA
  Duration: 1. 1. 2024 – 31. 12. 2027

• Diversity of vector-borne pathogenic and non-pathogenic microorganisms and potential therapy of zoonotic diseases caused by them
  Program: VEGA
  Duration: 1. 1. 2021 – 31. 12. 2024

• Host cell interaction with Coxiella burnetii: identification and utilization of novel therapeutic and diagnostic targets
  Program: SRDA
  Duration: 1. 7. 2020 – 30. 6. 2024

• Investigation of the Host – Parasite, Cell - Rickettsia Relationship, Monitored by Transcriptomic and Proteome Studies.
  Program: SRDA
  Duration: 1. 7. 2020 – 30. 6. 2024

• Discovery of clinically relevant proteins and their application in more reliable diagnostics of Q fever
  Program: VEGA
  Duration: 1. 1. 2018 – 31. 12. 2020

• The effect of selected natural compounds of plant origin (essential oils) on rickettsiae and ticks
  Program: VEGA
  Duration: 1. 1. 2016 – 31. 12. 2018